SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Artemis Therapeutics, Inc. – ‘10-K’ for 12/31/20 – ‘XML’

On:  Tuesday, 3/30/21, at 1:26pm ET   ·   For:  12/31/20   ·   Accession #:  1178913-21-1229   ·   File #:  0-24431

Previous ‘10-K’:  ‘10-K’ on 3/30/20 for 12/31/19   ·   Next:  ‘10-K’ on 3/3/22 for 12/31/21   ·   Latest:  ‘10-K/A’ on 5/3/23 for 12/31/22   ·   7 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/30/21  Artemis Therapeutics, Inc.        10-K       12/31/20   42:2M                                     Z-K Global Ltd./FA

Annual Report   —   Form 10-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML    317K 
 2: EX-31.1     Certification -- §302 - SOA'02 -- exhibit_31-1      HTML     17K 
 3: EX-32.1     Certification -- §906 - SOA'02 -- exhibit_32-1      HTML     14K 
10: R1          Document and Entity Information                     HTML     51K 
11: R2          Consolidated Balance Sheet                          HTML     72K 
12: R3          Consolidated Balance Sheet (Parenthetical)          HTML     33K 
13: R4          Consolidated Statement of Operation                 HTML     42K 
14: R5          Consolidated Statements of changes of               HTML     35K 
                shareholder's equity (Deficiency)                                
15: R6          Consolidated Statement of Cash Flows                HTML     45K 
16: R7          General                                             HTML     22K 
17: R8          Significant Accounting Policies                     HTML     27K 
18: R9          Commitments and Contingencies                       HTML     17K 
19: R10         Income Tax                                          HTML     42K 
20: R11         Warrants Issued to Investors                        HTML     19K 
21: R12         Computation of Net Loss per Share                   HTML     29K 
22: R13         Stock Capital                                       HTML     57K 
23: R14         Related Parties                                     HTML     17K 
24: R15         Subsequent Events                                   HTML     16K 
25: R16         Significant Accounting Policies (Policies)          HTML     49K 
26: R17         Income Tax (Tables)                                 HTML     38K 
27: R18         Warrants Issued to Investors (Tables)               HTML     20K 
28: R19         Computation of Net Loss per Share (Tables)          HTML     28K 
29: R20         Stock Capital (Tables)                              HTML     53K 
30: R21         Commitments and Contingencies (Details)             HTML     18K 
31: R22         Income Tax (Narrative) (Details)                    HTML     21K 
32: R23         Income Tax (Schedule of Deferred Income Taxes)      HTML     19K 
                (Details)                                                        
33: R24         Income Tax (Schedule of Net Operating Loss          HTML     18K 
                Carryforwards) (Details)                                         
34: R25         Warrants Issued to Investors (Details)              HTML     19K 
35: R26         Computation of Net Loss per Share (Schedule of      HTML     35K 
                Calculation of Basic Loss Per Share) (Details)                   
36: R27         Stock Capital (Narrative) (Details)                 HTML     42K 
37: R28         Stock Capital (Summary of Stock Option Activity)    HTML     41K 
                (Details)                                                        
38: R29         Stock Capital (Summary of Stock Option Exercise     HTML     30K 
                price) (Details)                                                 
39: R30         Related Parties (Narrative) (Details)               HTML     23K 
41: XML         IDEA XML File -- Filing Summary                      XML     71K 
40: EXCEL       IDEA Workbook of Financial Reports                  XLSX     40K 
 4: EX-101.INS  XBRL Instance -- atms-20201231                       XML    488K 
 6: EX-101.CAL  XBRL Calculations -- atms-20201231_cal               XML     70K 
 7: EX-101.DEF  XBRL Definitions -- atms-20201231_def                XML    211K 
 8: EX-101.LAB  XBRL Labels -- atms-20201231_lab                     XML    433K 
 9: EX-101.PRE  XBRL Presentations -- atms-20201231_pre              XML    325K 
 5: EX-101.SCH  XBRL Schema -- atms-20201231                         XSD     82K 
42: ZIP         XBRL Zipped Folder -- 0001178913-21-001229-xbrl      Zip     57K 


‘XML’   —   IDEA XML File — Filing Summary


This Document is an IDEA XML File.


                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<FilingSummary>
<Version> 3.21.1 </Version>
<ProcessingTime/>
<ReportFormat> html </ReportFormat>
<ContextCount> 64 </ContextCount>
<ElementCount> 196 </ElementCount>
<EntityCount> 1 </EntityCount>
<FootnotesReported> true </FootnotesReported>
<SegmentCount> 19 </SegmentCount>
<ScenarioCount> 0 </ScenarioCount>
<TuplesReported> false </TuplesReported>
<UnitCount> 4 </UnitCount>
<MyReports>
<Report instance="atms-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R1.htm </HtmlFileName>
<LongName> 00000001 - Document - Document and Entity Information </LongName>
<ReportType> Sheet </ReportType>
<Role> http://artemistherapeuticsinc.com/role/inks-daei1 </Role>
<ShortName> Document and Entity Information </ShortName>
<MenuCategory> Cover </MenuCategory>
<Position> 1 </Position>
</Report>
<Report instance="atms-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R2.htm </HtmlFileName>
<LongName> 00000002 - Statement - Consolidated Balance Sheet </LongName>
<ReportType> Sheet </ReportType>
<Role> http://artemistherapeuticsinc.com/role/inks-cbs </Role>
<ShortName> Consolidated Balance Sheet </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 2 </Position>
</Report>
<Report instance="atms-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R3.htm </HtmlFileName>
<LongName> 00000003 - Statement - Consolidated Balance Sheet (Parenthetical) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://artemistherapeuticsinc.com/role/inks-cbsp </Role>
<ShortName> Consolidated Balance Sheet (Parenthetical) </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 3 </Position>
</Report>
<Report instance="atms-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R4.htm </HtmlFileName>
<LongName> 00000004 - Statement - Consolidated Statement of Operation </LongName>
<ReportType> Sheet </ReportType>
<Role> http://artemistherapeuticsinc.com/role/inks-csoo </Role>
<ShortName> Consolidated Statement of Operation </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 4 </Position>
</Report>
<Report instance="atms-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R5.htm </HtmlFileName>
<LongName> 00000005 - Statement - Consolidated Statements of changes of shareholder's equity (deficiency) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://artemistherapeuticsinc.com/role/StatementsOfChangesOfShareholdersEquityDeficiency </Role>
<ShortName> Consolidated Statements of changes of shareholder's equity (deficiency) </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 5 </Position>
</Report>
<Report instance="atms-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R6.htm </HtmlFileName>
<LongName> 00000006 - Statement - Consolidated Statement of Cash Flows </LongName>
<ReportType> Sheet </ReportType>
<Role> http://artemistherapeuticsinc.com/role/inks-csocf </Role>
<ShortName> Consolidated Statement of Cash Flows </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 6 </Position>
</Report>
<Report instance="atms-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R7.htm </HtmlFileName>
<LongName> 00000007 - Disclosure - GENERAL </LongName>
<ReportType> Sheet </ReportType>
<Role> http://artemistherapeuticsinc.com/role/inks-g </Role>
<ShortName> GENERAL </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 7 </Position>
</Report>
<Report instance="atms-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R8.htm </HtmlFileName>
<LongName> 00000008 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES </LongName>
<ReportType> Sheet </ReportType>
<Role> http://artemistherapeuticsinc.com/role/inks-sap </Role>
<ShortName> SIGNIFICANT ACCOUNTING POLICIES </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 8 </Position>
</Report>
<Report instance="atms-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R9.htm </HtmlFileName>
<LongName> 00000009 - Disclosure - COMMITMENTS AND CONTINGENCIES </LongName>
<ReportType> Sheet </ReportType>
<Role> http://artemistherapeuticsinc.com/role/inks-cacl </Role>
<ShortName> COMMITMENTS AND CONTINGENCIES </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 9 </Position>
</Report>
<Report instance="atms-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R10.htm </HtmlFileName>
<LongName> 00000010 - Disclosure - INCOME TAX </LongName>
<ReportType> Sheet </ReportType>
<Role> http://artemistherapeuticsinc.com/role/inks-toi </Role>
<ShortName> INCOME TAX </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 10 </Position>
</Report>
<Report instance="atms-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R11.htm </HtmlFileName>
<LongName> 00000011 - Disclosure - WARRANTS ISSUED TO INVESTORS </LongName>
<ReportType> Sheet </ReportType>
<Role> http://artemistherapeuticsinc.com/role/WarrantsIssuedToInvestors </Role>
<ShortName> WARRANTS ISSUED TO INVESTORS </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 11 </Position>
</Report>
<Report instance="atms-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R12.htm </HtmlFileName>
<LongName> 00000012 - Disclosure - Computation of Net Loss per Share </LongName>
<ReportType> Sheet </ReportType>
<Role> http://artemistherapeuticsinc.com/role/ComputationOfNetLossPerShare </Role>
<ShortName> Computation of Net Loss per Share </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 12 </Position>
</Report>
<Report instance="atms-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R13.htm </HtmlFileName>
<LongName> 00000013 - Disclosure - STOCK CAPITAL </LongName>
<ReportType> Sheet </ReportType>
<Role> http://artemistherapeuticsinc.com/role/inks-sc </Role>
<ShortName> STOCK CAPITAL </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 13 </Position>
</Report>
<Report instance="atms-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R14.htm </HtmlFileName>
<LongName> 00000015 - Disclosure - RELATED PARTIES </LongName>
<ReportType> Sheet </ReportType>
<Role> http://artemistherapeuticsinc.com/role/RelatedParties </Role>
<ShortName> RELATED PARTIES </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 14 </Position>
</Report>
<Report instance="atms-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R15.htm </HtmlFileName>
<LongName> 00000016 - Disclosure - SUBSEQUENT EVENTS </LongName>
<ReportType> Sheet </ReportType>
<Role> http://artemistherapeuticsinc.com/role/SubsequentEvents </Role>
<ShortName> SUBSEQUENT EVENTS </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 15 </Position>
</Report>
<Report instance="atms-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R16.htm </HtmlFileName>
<LongName> 00000017 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://artemistherapeuticsinc.com/role/inks-sapp </Role>
<ShortName> SIGNIFICANT ACCOUNTING POLICIES (Policies) </ShortName>
<MenuCategory> Policies </MenuCategory>
<Position> 16 </Position>
</Report>
<Report instance="atms-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R17.htm </HtmlFileName>
<LongName> 00000018 - Disclosure - INCOME TAX (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://artemistherapeuticsinc.com/role/inks-toit </Role>
<ShortName> INCOME TAX (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://artemistherapeuticsinc.com/role/inks-toi </ParentRole>
<Position> 17 </Position>
</Report>
<Report instance="atms-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R18.htm </HtmlFileName>
<LongName> 00000019 - Disclosure - WARRANTS ISSUED TO INVESTORS (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://artemistherapeuticsinc.com/role/WarrantsIssuedToInvestorsTables </Role>
<ShortName> WARRANTS ISSUED TO INVESTORS (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://artemistherapeuticsinc.com/role/WarrantsIssuedToInvestors </ParentRole>
<Position> 18 </Position>
</Report>
<Report instance="atms-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R19.htm </HtmlFileName>
<LongName> 00000020 - Disclosure - Computation of Net Loss per Share (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://artemistherapeuticsinc.com/role/ComputationOfNetLossPerShareTables </Role>
<ShortName> Computation of Net Loss per Share (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://artemistherapeuticsinc.com/role/ComputationOfNetLossPerShare </ParentRole>
<Position> 19 </Position>
</Report>
<Report instance="atms-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R20.htm </HtmlFileName>
<LongName> 00000021 - Disclosure - STOCK CAPITAL (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://artemistherapeuticsinc.com/role/StockCapitalTables </Role>
<ShortName> STOCK CAPITAL (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://artemistherapeuticsinc.com/role/inks-sc </ParentRole>
<Position> 20 </Position>
</Report>
<Report instance="atms-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R21.htm </HtmlFileName>
<LongName> 00000022 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://artemistherapeuticsinc.com/role/CommitmentsAndContingenciesDetails </Role>
<ShortName> COMMITMENTS AND CONTINGENCIES (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://artemistherapeuticsinc.com/role/inks-cacl </ParentRole>
<Position> 21 </Position>
</Report>
<Report instance="atms-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R22.htm </HtmlFileName>
<LongName> 00000023 - Disclosure - INCOME TAX (Narrative) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://artemistherapeuticsinc.com/role/Disclosure-TAXESONINCOMENarrativeDetails </Role>
<ShortName> INCOME TAX (Narrative) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://artemistherapeuticsinc.com/role/inks-toit </ParentRole>
<Position> 22 </Position>
</Report>
<Report instance="atms-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R23.htm </HtmlFileName>
<LongName> 00000024 - Disclosure - INCOME TAX (Schedule of Deferred Income Taxes) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://artemistherapeuticsinc.com/role/IncomeTaxScheduleOfDeferredIncomeTaxesDetails </Role>
<ShortName> INCOME TAX (Schedule of Deferred Income Taxes) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://artemistherapeuticsinc.com/role/inks-toit </ParentRole>
<Position> 23 </Position>
</Report>
<Report instance="atms-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R24.htm </HtmlFileName>
<LongName> 00000025 - Disclosure - INCOME TAX (Schedule of Net Operating Loss Carryforwards) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://artemistherapeuticsinc.com/role/IncomeTaxScheduleOfNetOperatingLossCarryforwardsDetails </Role>
<ShortName> INCOME TAX (Schedule of Net Operating Loss Carryforwards) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://artemistherapeuticsinc.com/role/inks-toit </ParentRole>
<Position> 24 </Position>
</Report>
<Report instance="atms-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R25.htm </HtmlFileName>
<LongName> 00000026 - Disclosure - WARRANTS ISSUED TO INVESTORS (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://artemistherapeuticsinc.com/role/WarrantsIssuedToInvestorsDetails </Role>
<ShortName> WARRANTS ISSUED TO INVESTORS (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://artemistherapeuticsinc.com/role/WarrantsIssuedToInvestorsTables </ParentRole>
<Position> 25 </Position>
</Report>
<Report instance="atms-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R26.htm </HtmlFileName>
<LongName> 00000027 - Disclosure - Computation of Net Loss per Share (Schedule of Calculation of Basic Loss Per Share) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://artemistherapeuticsinc.com/role/ComputationOfNetLossPerShareScheduleOfCalculationOfBasicLossPerShareDetails </Role>
<ShortName> Computation of Net Loss per Share (Schedule of Calculation of Basic Loss Per Share) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://artemistherapeuticsinc.com/role/ComputationOfNetLossPerShareTables </ParentRole>
<Position> 26 </Position>
</Report>
<Report instance="atms-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R27.htm </HtmlFileName>
<LongName> 00000028 - Disclosure - STOCK CAPITAL (Narrative) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://artemistherapeuticsinc.com/role/StockCapitalNarrativeDetails </Role>
<ShortName> STOCK CAPITAL (Narrative) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://artemistherapeuticsinc.com/role/StockCapitalTables </ParentRole>
<Position> 27 </Position>
</Report>
<Report instance="atms-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R28.htm </HtmlFileName>
<LongName> 00000029 - Disclosure - STOCK CAPITAL (Summary of Stock Option Activity) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://artemistherapeuticsinc.com/role/StockCapitalSummaryOfStockOptionActivityDetails </Role>
<ShortName> STOCK CAPITAL (Summary of Stock Option Activity) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://artemistherapeuticsinc.com/role/StockCapitalTables </ParentRole>
<Position> 28 </Position>
</Report>
<Report instance="atms-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R29.htm </HtmlFileName>
<LongName> 00000030 - Disclosure - STOCK CAPITAL (Summary of Stock Option Exercise price) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://artemistherapeuticsinc.com/role/StockCapitalSummaryOfStockOptionExercisePriceDetails </Role>
<ShortName> STOCK CAPITAL (Summary of Stock Option Exercise price) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://artemistherapeuticsinc.com/role/StockCapitalTables </ParentRole>
<Position> 29 </Position>
</Report>
<Report instance="atms-20201231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R30.htm </HtmlFileName>
<LongName> 00000031 - Disclosure - RELATED PARTIES (Narrative) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://artemistherapeuticsinc.com/role/RelatedPartiesNarrativeDetails </Role>
<ShortName> RELATED PARTIES (Narrative) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://artemistherapeuticsinc.com/role/RelatedParties </ParentRole>
<Position> 30 </Position>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<LongName> All Reports </LongName>
<ReportType> Book </ReportType>
<ShortName> All Reports </ShortName>
</Report>
</MyReports>
<InputFiles>
<File> atms-20201231.xml </File>
<File> atms-20201231.xsd </File>
<File> atms-20201231_cal.xml </File>
<File> atms-20201231_def.xml </File>
<File> atms-20201231_lab.xml </File>
<File> atms-20201231_pre.xml </File>
</InputFiles>
<SupplementalFiles/>
<BaseTaxonomies>
<BaseTaxonomy> http://fasb.org/us-gaap/2020-01-31 </BaseTaxonomy>
<BaseTaxonomy> http://fasb.org/srt/2020-01-31 </BaseTaxonomy>
<BaseTaxonomy> http://xbrl.sec.gov/dei/2020-01-31 </BaseTaxonomy>
</BaseTaxonomies>
<HasPresentationLinkbase> true </HasPresentationLinkbase>
<HasCalculationLinkbase> true </HasCalculationLinkbase>
</FilingSummary>


7 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/19/19  Manuka, Inc.                      10-Q        6/30/19   43:2.4M                                   Z-K Global Ltd./FA
10/25/17  Manuka, Inc.                      8-K:1,3,5,910/25/17    4:558K                                   Z-K Global Ltd./FA
 8/29/16  Manuka, Inc.                      8-K:1,2,3,5 8/29/16    5:1M                                     Z-K Global Ltd./FA
 8/09/11  Artemis Therapeutics, Inc.        DEF 14A     8/09/11    1:626K                                   Z-K Global Ltd./FA
 9/24/10  Artemis Therapeutics, Inc.        8-K:5,9     9/24/10    5:52K                                    Z-K Global Ltd./FA
 4/04/08  Artemis Therapeutics, Inc.        8-K:5,9     4/04/08    2:5K                                     Z-K Global Ltd./FA
11/14/02  Artemis Therapeutics, Inc.        10QSB       9/30/02    6:113K                                   Bowne & C… Smartedgar/FA
Top
Filing Submission 0001178913-21-001229   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., Apr. 30, 11:52:39.1am ET